GlassScriptPhysician profile
Brenda E Sawyer
NPI 1255564621
$8,681.77
in general payments reported to CMS, 2019-2025
57 companies · $2,340 in 2025
The $2,340 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,051 · 2022: $1,044 · 2023: $1,664 · 2024: $2,582 · 2025: $2,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,586.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,215.59 | 2021-2025 | |
| Lilly USA, LLC | $726.65 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $709.26 | 2023-2025 | |
| Amgen INC. | $680.93 | 2021-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $631.25 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $523.26 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $471.58 | 2021-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $316.81 | 2021-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $309.92 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Phathom Pharmaceuticals, INC. | $281.56 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $258.48 | 2021-2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $238.58 | 2021-2025 | Trintellix |
| Novartis Pharmaceuticals Corporation | $187.68 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $179.11 | 2023-2025 | Gemtesa |
| Eisai INC. | $171.64 | 2024-2025 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $158.35 | 2021-2025 | Nexletol |
| Corium, LLC | $143.03 | 2022-2024 | Adlarity, Azstarys |
| Idorsia Pharmaceuticals US INC | $109.35 | 2023-2024 | Tryvio, Quviviq |
| Radius Health, INC. | $86.52 | 2025 | Tymlos |
| Lundbeck LLC | $85.26 | 2023-2024 | Rexulti, Vyepti |
| Axsome Therapeutics, INC. | $85.11 | 2024-2025 | Symbravo, Sunosi, Auvelity |
| Teva Pharmaceuticals USA, INC. | $75.51 | 2024-2025 | Ajovy |
| Merck Sharp & Dohme LLC | $67.89 | 2021-2025 | Gardasil 9, Capvaxive |
| Biohaven Pharmaceuticals, INC. | $62.69 | 2021 | |
| Janssen Pharmaceuticals, INC | $58.62 | 2023-2024 | Xarelto |
| Ardelyx, INC. | $54.09 | 2024-2025 | Ibsrela |
| Dexcom, INC. | $52.58 | 2023-2025 | Dexcom G6 Transmitter |
| Dynavax Technologies Corporation | $49.21 | 2023-2024 | Heplisav-B |
| Edwards Lifesciences Corporation | $48.86 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Astellas Pharma US INC | $46.09 | 2021-2025 | Veozah |
| Paratek Pharmaceuticals, INC. | $43.86 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $36.73 | 2022 | |
| Exact Sciences Corporation | $36.38 | 2025 | Cologuard Collection Kit |
| Tolmar, INC. | $35.30 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $29.09 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $27.38 | 2021-2024 | Zoryve |
| Biogen, INC. | $26.06 | 2025 | Leqembi |
| Insulet Corporation | $24.21 | 2021 | |
| Endo Pharmaceuticals INC. | $22.56 | 2024 | Aveed, Xiaflex |
| Otsuka America Pharmaceutical, INC. | $22.56 | 2025 | Rexulti |
| Seqirus USA INC | $21.00 | 2024 | Fluad, Flucelvax |
| Almatica Pharma LLC | $20.57 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.91 | 2022 | |
| Vanda Pharmaceuticals INC. | $19.37 | 2024 | Hetlioz, Fanapt |
| Atricure, INC. | $19.32 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Genentech USA, INC. | $18.35 | 2021 | |
| Philips North America LLC | $18.18 | 2024 | (Ck6) Holter |
| Viatris Specialty LLC | $17.46 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $17.25 | 2023 | Inspire |
| Shield Therapeutics INC | $16.74 | 2024 | |
| Sandoz INC. | $16.57 | 2025 | Jubbonti |
| Sunovion Pharmaceuticals INC. | $16.31 | 2022 | |
| Medtronic, INC. | $15.07 | 2025 | Closurerfs |
| Xeris Pharmaceuticals, INC. | $14.82 | 2025 | Gvoke Hypopen |
| Currax Pharmaceuticals LLC | $13.95 | 2024 | Contrave |
| Antares Pharma, INC. | $13.77 | 2025 | Xyosted |
| Bausch Health US, LLC | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.